Related references
Note: Only part of the references are listed.A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD
Janet K. Johnson et al.
JOURNAL OF ATTENTION DISORDERS (2020)
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study
Sharon B. Wigal et al.
JOURNAL OF ATTENTION DISORDERS (2020)
Attention-deficit hyperactivity disorder
Jonathan Posner et al.
LANCET (2020)
Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?
Silvia Grazioli et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial
Robert L. Findling et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2019)
Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study
Joseph Biederman et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial
Sara Dehbozorghi et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
The effect of memantine in adult patients with attention deficit hyperactivity disorder
Soleiman Mohammadzadeh et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2019)
Adverse Drug Reactions Related to Mood and Emotion in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder A Comparative Analysis of the US Food and Drug Administration Adverse Event Reporting System Database
Marco Pozzi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
A strategy for increasing the efficiency of psychopharmacological treatment of hyperkinetic behavior disorder with pantogam
T. A. Kupriyanova et al.
Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova (2018)
Light up ADHD: I. Cortical hemodynamic responses measured by functional Near Infrared Spectroscopy (fNIRS) Special Section on Translational and Neuroscience Studies in Affective Disorders Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summarise relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders
Maddalena Mauri et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Adverse drug events related to mood and emotion in paediatric patients treated for ADHD: A meta-analysis
Marco Pozzi et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Psychotropic Polypharmacy Among Youths With Serious Emotional and Behavioral Disorders Receiving Coordinated Care Services
Benjamin Wu et al.
PSYCHIATRIC SERVICES (2018)
Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
Josephine Elia et al.
NATURE COMMUNICATIONS (2018)
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
Raimunda S. S. Azevedo et al.
SCIENTIFIC REPORTS (2018)
ADHD in children and youth: Part 2-Treatment
Mark E. Feldman et al.
PAEDIATRICS & CHILD HEALTH (2018)
Memantine in the Treatment of Executive Function Deficits in Adults With ADHD: A Pilot-Randomized Double-Blind Controlled Clinical Trial
Joseph Biederman et al.
JOURNAL OF ATTENTION DISORDERS (2017)
Long-Term, Open-Label, Safety Study of Edivoxetine Monotherapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Emel Serap Monkul Nery et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2017)
Pharmacotherapy of attention deficit hyperactivity disorder in children: the results of a multicenter double-blind placebo-controlled study of hopantenic acid
N. N. Zavadenko et al.
Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova (2017)
Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial
Ruth E. Cooper et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Agomelatine as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial
Elaheh Salardini et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2016)
Centrally acting non-narcotic antitussives prevent hyperactivity in mice: Involvement of GIRK channels
Fumio Soeda et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2016)
Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation
Natalie Matosin et al.
ACTA NEUROPATHOLOGICA (2015)
Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD
Ganesh Moorthy et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2015)
Annual Research Review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents
Guilherme V. Polanczyk et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2015)
Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
Kenneth S. Koblan et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Effectiveness of oral tipepidine administration for children with attention deficit/hyperactivity disorder: A 4-week, open-label clinical study
Akemi Tomoda et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2015)
Further human evidence for striatal dopamine release induced by administration of a†9-tetrahydrocannabinol (THC): selectivity to limbic striatum
Matthijs G. Bossong et al.
PSYCHOPHARMACOLOGY (2015)
Attention-deficit/hyperactivity disorder
Stephen V. Faraone et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
AZD3480, a Novel Nicotinic Receptor Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
Alexandra S. Potter et al.
BIOLOGICAL PSYCHIATRY (2014)
Duloxetine in Adults With ADHD: A Randomized, Placebo-Controlled Pilot Study
Mathieu Bilodeau et al.
JOURNAL OF ATTENTION DISORDERS (2014)
A Randomized Trial of Edivoxetine in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
Daniel Y. Lin et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2014)
A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder
Aurelija Jucaite et al.
PSYCHOPHARMACOLOGY (2014)
Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study
Tsuyoshi Sasaki et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Clinical Outcomes from an Open-Label Study of Edivoxetine Use in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
Ling Jin et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2013)
Effect of Psychostimulants on Brain Structure and Function in ADHD: A Qualitative Literature Review of Magnetic Resonance Imaging-Based Neuroimaging Studies
Thomas J. Spencer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD
Antonio Molina-Carballo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD
Earle E. Bain et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression
Ruth Cunill et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
A pilot open label prospective study of memantine monotherapy in adults with ADHD
Craig B. H. Surman et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2013)
Attention-deficit/hyperactivity disorder: an update on medication adherence and persistence in children, adolescents and adults
Rana Ahmed et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2013)
A Translational Approach to Evaluate the Efficacy and Safety of the Novel AMPA Receptor Positive Allosteric Modulator Org 26576 in Adult Attention-Deficit/Hyperactivity Disorder
Lenard A. Adler et al.
BIOLOGICAL PSYCHIATRY (2012)
Randomized Clinical Study of a Histamine H-3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder
Richard H. Weisler et al.
CNS DRUGS (2012)
Double-blind controlled trial of venlafaxine for treatment of adults with attention deficit/hyperactivity disorder
Shahrokh Amiri et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)
Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study
Morteza Jafarinia et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)
A Randomized, Double-Blind, Crossover Comparison of MK-0929 and Placebo in the Treatment of Adults With ADHD
Anna Rivkin et al.
JOURNAL OF ATTENTION DISORDERS (2012)
Agomelatine Treatment with Adolescents with ADHD
Helmut Niederhofer
JOURNAL OF ATTENTION DISORDERS (2012)
A Phase 2a Randomized, Parallel Group, Dose-Ranging Study of Molindone in Children with Attention-Deficit/Hyperactivity Disorder and Persistent, Serious Conduct Problems
Jennifer Dugan Stocks et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2012)
A Randomized Pilot Study of the Efficacy and Safety of ABT-089, a Novel α4β2 Neuronal Nicotinic Receptor Agonist, in Adults With Attention-Deficit/Hyperactivity Disorder
Earle E. Bain et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Randomized Controlled Study of the Histamine H3 Inverse Agonist MK-0249 in Adult Attention-Deficit/Hyperactivity Disorder
W. Joseph Herring et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Multiple Pharmacological Actions of Centrally Acting Antitussives - Do They Target G Protein-Coupled Inwardly Rectifying K+ (GIRK) Channels?
Kazuo Takahama
JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)
Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
George Apostol et al.
PSYCHOPHARMACOLOGY (2012)
Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open-label study
Javad Mahmoudi-Gharaei et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
Emma Barkus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Abnormal Amygdalar Activation and Connectivity in Adolescents With Attention-Deficit/Hyperactivity Disorder
Jonathan Posner et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2011)
Safety and Efficacy of ABT-089 in Pediatric Attention-Deficit/Hyperactivity Disorder: Results from Two Randomized Placebo-Controlled Clinical Trials
Timothy E. Wilens et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2011)
Basal Ganglia Surface Morphology and the Effects of Stimulant Medications in Youth With Attention Deficit Hyperactivity Disorder
Loren J. Sobel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled clinical trial
Forough Riahi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Operant Sensation Seeking Requires Metabotropic Glutamate Receptor 5 (mGluR5)
Christopher M. Olsen et al.
PLOS ONE (2010)
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Viktoria Simon et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Dopamine D4 Receptors Regulate AMPA Receptor Trafficking and Glutamatergic Transmission in GABAergic Interneurons of Prefrontal Cortex
Eunice Y. Yuen et al.
JOURNAL OF NEUROSCIENCE (2009)
Can recreational doses of THC produce significant dopamine release in the human striatum?
Paul R. A. Stokes et al.
NEUROIMAGE (2009)
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
Matthijs G. Bossong et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder
Alexandra S. Potter et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Synthesis and structure -: Activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel α4β2 nicotinic acetylcholine receptor selective Agonists
Jianguo Ji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Central nicotinic cholinergic systems: A role in the cognitive dysfunction in Attention-Deficit/Hyperactivity Disorder?
Alexandra S. Potter et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: Results of a pilot study
Timothy E. Wilens et al.
BIOLOGICAL PSYCHIATRY (2006)
Neuronal nicotinic receptors: from structure to pathology
C Gotti et al.
PROGRESS IN NEUROBIOLOGY (2004)
Cannabis induced dopamine release: an in-vivo SPECT study
LNP Voruganti et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2001)
Share Paper
